Answers are grounded in this paper and cite their sources.
NBCA injection with the Variclose device seems to be a feasible, effective and safe treatment in GSV incompetence. Long-term follow-up studies and randomized controlled trials are needed to achieve high-quality evidence.
No takes yet. Share an insight, caveat, or question.
Bissacco et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: